NIT
PGNX

NumerixS Investment Technologies’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

NumerixS Investment Technologies’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6,400
Closed -$26K – 1426
2018
Q4 		$26K Sell
6,400
-4,800
-43% -$24.4K 0.01% 889
2018
Q3 		$69K Sell
11,200
-4,600
-29% -$35.3K 0.01% 904
2018
Q2 		$128K Buy
15,800
+9,800
+163% +$74.8K 0.03% 671
2018
Q1 		$44K Buy
+6,000
New +$39.9K 0.01% 834
2017
Q3 		– Sell
-8,700
Closed -$59K – 1430
2017
Q2 		$59K Sell
8,700
-21,100
-71% -$156K 0.01% 936
2017
Q1 		$281K Sell
29,800
-5,300
-15% -$52.9K 0.03% 608
2016
Q4 		$303K Buy
+35,100
New +$259K 0.04% 547
2016
Q2 		– Sell
-30,136
Closed -$131K – 1291
2016
Q1 		$131K Sell
30,136
-900
-3% -$4.01K 0.02% 791
2015
Q4 		$190K Buy
31,036
+17,936
+137% +$118K 0.02% 704
2015
Q3 		$75K Buy
+13,100
New +$101K 0.01% 620

Other funds holding PGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

NumerixS Investment Technologies's PGNX Position: Q1 2019 in Review

NumerixS Investment Technologies sold out of Progenics Pharmaceuticals Inc (PGNX) in Q1 2019, closing a stake of 6,400 shares — an estimated $26K sold.

NumerixS Investment Technologies first reported a position in PGNX in Q3 2015 and held it in 10 quarters. The position peaked at $303K in Q4 2016. 148 funds tracked by Wall St. Rank hold PGNX as of Q1 2019.

  • NumerixS Investment Technologies reported no remaining Progenics Pharmaceuticals Inc position as of Q1 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 6,400 Progenics Pharmaceuticals Inc shares in Q1 2019, an estimated $26K.
  • NumerixS Investment Technologies first reported a position in Progenics Pharmaceuticals Inc in Q3 2015 and held it in 10 quarters.
  • NumerixS Investment Technologies's Progenics Pharmaceuticals Inc position peaked at $303K in Q4 2016.
  • 148 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q1 2019.

Based on NumerixS Investment Technologies's 13F filing for Q1 2019, filed 10 May 2019.